Literature DB >> 21865132

Mesenchymal niches of bone marrow in cancer.

Ander Abarrategi1, Luis Marińas-Pardo, Isabel Mirones, Esther Rincón, Javier García-Castro.   

Abstract

Over the last decade, genetic and cell biology studies have indicated that tumour growth is not only determined by malignant cancer cells themselves, but also by the tumour microenvironment. Cells present in the tumour microenvironment include fibroblasts, vascular, smooth muscle, adipocytes, immune cells and mesenchymal stem cells (MSC). The nature of the relationship between MSC and tumour cells appears dual and whether MSC are pro- or anti-tumorigenic is a subject of controversial reports. This review is focused on the role of MSC and bone marrow (BM) niches in cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865132     DOI: 10.1007/s12094-011-0706-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  76 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Mesenchymal stem cells enhance growth and metastasis of colon cancer.

Authors:  Kei Shinagawa; Yasuhiko Kitadai; Miwako Tanaka; Tomonori Sumida; Michiyo Kodama; Yukihito Higashi; Shinji Tanaka; Wataru Yasui; Kazuaki Chayama
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 3.  Stem cells in tumor angiogenesis.

Authors:  Shentong Fang; Petri Salven
Journal:  J Mol Cell Cardiol       Date:  2010-11-01       Impact factor: 5.000

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

Authors:  F Sanz-Rodríguez; A Hidalgo; J Teixidó
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

Review 6.  Concise review: mesenchymal tumors: when stem cells go mad.

Authors:  Alexander B Mohseny; Pancras C W Hogendoorn
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

Review 7.  Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system.

Authors:  Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2011-04-01       Impact factor: 9.941

Review 8.  Involvement of endothelial progenitor cells in tumor vascularization.

Authors:  Alexandre Patenaude; Jeremy Parker; Aly Karsan
Journal:  Microvasc Res       Date:  2010-01-18       Impact factor: 3.514

9.  Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.

Authors:  Patrick P Lin; Yongxing Wang; Guillermina Lozano
Journal:  Sarcoma       Date:  2010-10-05

Review 10.  Contribution of bone microenvironment to leukemogenesis and leukemia progression.

Authors:  F Ayala; R Dewar; M Kieran; R Kalluri
Journal:  Leukemia       Date:  2009-09-03       Impact factor: 11.528

View more
  9 in total

1.  Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated Src and Janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells.

Authors:  Alain Zgheib; Sylvie Lamy; Borhane Annabi
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

2.  Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow.

Authors:  Younghun Jung; Jingcheng Wang; Eunsohl Lee; Samantha McGee; Janice E Berry; Kenji Yumoto; Jinlu Dai; Evan T Keller; Yusuke Shiozawa; Russell S Taichman
Journal:  Mol Cancer Res       Date:  2014-08-19       Impact factor: 5.852

3.  Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation.

Authors:  Stefania Lama; Amalia Luce; Giuseppe Bitti; Pilar Chacon-Millan; Annalisa Itro; Pasquale Ferranti; Giovanni D'Auria; Marcella Cammarota; Giovanni Francesco Nicoletti; Giuseppe Andrea Ferraro; Chiara Schiraldi; Michele Caraglia; Evzen Amler; Paola Stiuso
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-08

Review 4.  Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.

Authors:  Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Tina Vosoughi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-07-20

5.  Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.

Authors:  Younghun Jung; Jin Koo Kim; Yusuke Shiozawa; Jingcheng Wang; Anjali Mishra; Jeena Joseph; Janice E Berry; Samantha McGee; Eunsohl Lee; Hongli Sun; Jianhua Wang; Taocong Jin; Honglai Zhang; Jinlu Dai; Paul H Krebsbach; Evan T Keller; Kenneth J Pienta; Russell S Taichman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.

Authors:  Xue Yang; Jing Hou; Zhipeng Han; Ying Wang; Chong Hao; Lixin Wei; Yufang Shi
Journal:  Cell Biosci       Date:  2013-01-21       Impact factor: 7.133

7.  In vivo ectopic implantation model to assess human mesenchymal progenitor cell potential.

Authors:  Ander Abarrategi; Raquel Perez-Tavarez; Miguel Angel Rodriguez-Milla; Isabel Cubillo; Francisca Mulero; Arantzazu Alfranca; Jose Luis Lopez-Lacomba; Javier García-Castro
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

Review 8.  Steroid Therapy and Steroid Response in Autoimmune Pancreatitis.

Authors:  Hiroyuki Matsubayashi; Hirotoshi Ishiwatari; Kenichiro Imai; Yoshihiro Kishida; Sayo Ito; Kinichi Hotta; Yohei Yabuuchi; Masao Yoshida; Naomi Kakushima; Kohei Takizawa; Noboru Kawata; Hiroyuki Ono
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

9.  Androgen attenuates antitumor effects of gastric cancer cells by bone marrow mesenchymal stem cells via restricting the JNK signaling activation.

Authors:  Linsong Mu; Wu Sui; Yang Lin; Wentao Yu; Hailong Su; Xiang Yu; Chengkun Qin
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.